In view of Bering's (1951) confirmatory work on the Rosenow antibody-antigen skin reaction in idiopathic epilepsy, it was decided to carry out similar tests at Shenley Hospital with schizophrenic and epileptic groups of patients, in order to see if further confirmation could be obtained, particularly in schizophrenia.
Rosenow's findings have been reported extensively (1947, 1948a, 1948b) , but so far the only confirmatory work is that of Bering. In essence, Rosenow believes that a streptococcus of the alpha viridans type plays a significant part in the aetiology of a wide variety of diseases, among which are included epilepsy, schizophrenia, and arthritis. He claims to have demonstrated, using a variety of tests, that patients suffering from any of these groups of diseases harbour alpha-haemolytic streptococci of different types in the naso-pharynx, which are in some ways specific for patients suffering from that particular disorder or group of disorders. One of the ways in which this can be most readily demonstrated is by a cutaneous reaction to an intradermal injection of specific streptococcal antibody, or antigen (Rosenow, 1948c) . For practical purposes he finds that a specially prepared antibody, designated " thermal antibody ", and prepared according to a carefully described technique, is equivalent to natural antibody prepared by the immunization of animals. According to Rosenow (1948b) , this substance, when injected into the skin of patients suffering from diseases similar to those in which the streptococci, from which antibodies have been prepared, were first isolated, produces a higher proportion of large erythematous reactions than when the same substance is injected into well persons, or persons suffering from other disorders. The differences in response so produced appear convincing even without careful statistical analysis. Furthermore, Bering (1951) demonstrated statistically in his own experiments that these findings, in epilepsy at least, are significant beyond all reasonable doubt.
Methods
Material for use in testing was obtained direct from Dr. Rosenow, and had been prepared by him according to the techniques described and found to give significant results in patients in the U.S.A. These were sent to us in rubber-capped bottles, labelled A, B, C, and F. Substance A consisted of thermal antibody prepared from cultures of alpha-haemolytic streptococci, isolated from the naso-pharynx of patients suffering from schizophrenia, B from patients with epilepsy, C from patients with arthritis, and F from people who were clinically well at the time. Two sets of these were sent over by air, and one set (selected by tossing a penny) was immediately returned to Dr. Rosenow for testing on American patients to confirm that no change had occurred as a result of transit, and he was in fact able to confirm that this was so.
Case Material Patients known personally to only one of us (W. P. G.) were selected according to the diagnosis. Later, after all the tests had been performed, this was confirmed or rectified by both of us, on scrutinizing the case records and interviewing patients where any doubt existed. Atypical features were also noted. All patients were submitted to testing by three observers, under standard conditions of lighting. There was some variation in room temperature, because most patients were tested on cold days, and the others when the weather was warmer.
According to Dr. Rosenow (personal communication) the temperature of the wards had no significant influence on cutaneous reactions in his series.
Patients.-These were male patients, mainly long-stay, living for the most part in close association with one another, although suffering from different disorders.
Sixty-seven patients were tested in all, and among these were 40 schizophrenics, 16 epileptics, and 11 patients suffering neither from epilepsy nor schizophrenia, to act as controls. Of this last group there were five with general paralysis of the insane (non-convulsive), two manic-depressives, and four with personality disorders.
Technique
The technique was applied as described by Rosenow (1948b 0-15 0-24 0-7 0-10 All responses were measured by square centimetres of erythema, which was usually maximal about five minutes after injection, and agreed upon by all three observers, using a standard series of circles on a transparent x-ray film, supplied by Dr. Rosenow.
Positive reactions, as defined by Rosenow (1948b) taken as critical, we found the above in schizophrenic patients.
It was also noted that of the 16 patients reacting positively to A, eight also reacted positively to B, and one to C. Fourteen out of 40 schizophrenic patients showed some degree of reaction to all injections, but in 10 of these the reactions to A and B were greater than C and F. When the results of the schizophrenic group were examined according to the positive or negative reactions, no significant difference was found in the two groups, each containing an equal proportion of borderline or doubtful If we examine the above results we see that a slightly greater proportion of schizophrenics react to A than to B, and a slightly greater proportion of epileptics react to B than to A. However, both groups show a significantly greater proportion of reactors to A and B than they do to C and F. Considered in terms of the actual size of response rather than the number of persons reacting in any group, again we find that both schizophrenics and epileptics show a greater average size of response to A and B than they do to C and F. However, this tendency is also present to an equivalent degree in the control groups. Also, the control group shows a greater number of positive reactors to A and B than to C and F. It is our opinion, therefore, that these results are in no way specific for the groups tested. Looking at Rosenow's (1948b) Here again, there is a large difference, in that only 40% of our schizophrenics were positive to A, 37-5 % of our epileptics were positive to B, and 36 and 27% of our miscellaneous group, includirg patients with G.P.I., were positive to A and B respectively. Although the numbers of cases we have tested is small in comparison with Rosenow's series (1948b), in the schizophrenic group at least the discrepancy between the proportion of positive reactors and average responses and those found by Rosenow (1948b) fails to support his findings. In our opinion, these substances are not specific in any way for the groups of chronic patients tested. An explanation is still required, however, as to why it is that patients of all groups react more to A and B antibodies than they do to C and F. This is also true of Rosenow's findings.
These results agree in principle with those obtained by one of us (H. H. F.) in former studies (1953-54) which were carried out entirely blind. Dr. Rosenow had sent over four antibodies labelled A, B, C, and F, together with a control solution containing no antibodies. Tests were carried out in September, 1953, using eight normal controls at first from the laboratory and nursing staff. Amongst others some very large reactions were obtained, but these were due to the syringes not having been allowed to cool down sufficiently after sterilization. When this error was excluded only small reactions occurred.
Then 19 male schizophrenics and 21 male controls were selected from their case notes, the individual patients being unknown to the experimenter when they came up for injection. Only after the results had been recorded by three observers were the identity and diagnoses of the patients revealed. Then the findings obtained in the individual patients were tabulated according to the symbol of the substances to which they reacted, and these results were sent to Dr. J. N. Cumings of the National Hospital, Queen's Square, London, who had kindly agreed to act as " intermediary ". After this, Dr. Rosenow made known the nature of the solutions to Dr. Cumings, who then gave us the relevant information, that is, as to whether A, B, C, and F were derived from schizophrenic, epileptic, arthritic, or well person groups. The results were entirely contradictory. Dr. Rosenow was informed of this, and at his request the solutions were returned to him for re-testing. He reported that some of the antibodies had deteriorated. It was then decided to repeat the test the following summer (1954) These results differ only in a few minor respects from those described in the main part of this paper, namely, that (1) From our findings we may conclude that (1) thermal antibodies prepared by Dr. Rosenow from streptococci, isolated and cultured from groups of patients with schizophrenia (A) and epilepsy (B), produce larger reactions when injected into patients suffering from schizophrenia and epilepsy than do antibodies derived from streptococci, isolated and cultured from patients suffering from arthritis (C), or well persons (F).
Likewise, these same substances A and B produce a greater proportion of positive responses in patients suffering from epilepsy and schizophrenia than do substances C and F.
In a control series of patients suffering from neither epilepsy nor schizophrenia the average responses are slightly greater to A and B than to C and F. The proportion of positive responses is also greater, but less than half of that found in the schizophrenic group.
An interesting impression requiring further investigation is that people who are clinically well and patients in any of the groups tested who appear to behave relatively normally tend to react negatively helpful cooperation and encouragement in carrying out to all four substances. However, it was not the this study, and Dr. S. T. Hayward, of Shenley Hospital, purpose of this paper to establish this point.
for permission to carry out the work.
